Read the rest here: CRISPR Therapeutics Announces Departure of Board Member
Read the rest here: CRISPR Therapeutics Announces Departure of Board Member
See more here: BioCardia Reports Fourth Quarter and Full Year 2022 Business Highlights and Financial Results
See more here: Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
Originally posted here: Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome...
Read more from the original source: Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster...
Read this article: Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
Excerpt from: New Data Presented at AD/PD™ 2023 Show Biogen’s BIIB080 (MAPT ASO) Substantially Reduced Tau Protein Levels in Patients with Early-stage...
Originally posted here: Aquestive Therapeutics Expands License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film to Additional Global Markets
Continued here: Lucy Scientific Discovery Appoints Former B.C. Solicitor General Kash Heed as a Special Advisor
More here: Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy...
Recent Comments